Oral Manifestation in Patients With SARS-CoV2 Infection.
NCT04821986 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 583
Last updated 2021-11-05
Summary
The oral cavity is particularly susceptible to viral infection with several viruses such as herpes simplex virus, cytomegalovirus and Zika virus because of its structures, especially salivary glands and soft tissues Moreover, oral mucosa can be affected by secondary pathological process of a bacterial or fungal nature due to viral immunosuppression. The oral cavity could be considered a "biological barometer" of both viral infection and viral immunosuppression advancement .
Conditions
- SARS-CoV Infection
Sponsors & Collaborators
-
Fayoum University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-01
- Primary Completion
- 2021-09-30
- Completion
- 2021-10-15
Countries
- Egypt
Study Locations
More Related Trials
-
Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions
NCT04348240 ·Status: COMPLETED
-
Recurrent Salivary Gland Infections in Covid-19
NCT05890547 ·Status: UNKNOWN
-
Prevalence of Oral Mucosal Alterations in Mucocutaneous Ocular Disorders
NCT03679988 ·Status: UNKNOWN
-
Oral Mucosal Lesions Among Smokers in an Egyptian Population Study.
NCT03299634 ·Status: UNKNOWN
-
Relationship Between Oral Findings and Salivary Factors in Sars-Cov-2 Patients
NCT05476848 ·Status: COMPLETED ·Phase: NA
-
SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling
NCT04460638 ·Status: COMPLETED
-
Use of Saliva for COVID-19 Diagnosis
NCT04953039 ·Status: COMPLETED
-
Effect of Wearing Face Masks on Salivary Parameters and Halitosis
NCT04914208 ·Status: COMPLETED ·Phase: NA
-
Oral Side Effects of COVID-19 Vaccine
NCT04706156 ·Status: UNKNOWN
-
Study of Oral Bacteria in Patients With Dry Mouth
NCT00048685 ·Status: COMPLETED
-
Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health
NCT04632004 ·Status: COMPLETED ·Phase: NA
-
Molecular Assessment of Oral Mutans Streptococcus Isolated From Different Patients
NCT03802669 ·Status: COMPLETED
-
Prevalence of Oral Mucosal Alterations In a Sample of Egyptian Patients With Cardiovascular Diseases: A Hospital- Based Cross-Sectional Study
NCT04511403 ·Status: UNKNOWN
-
Oral and Olfactory Complications of Recovered COVID-19 Patients
NCT04791436 ·Status: RECRUITING
-
Effectiveness of Zinc Supplementation in Management of Patients With Symptomatic Benign Migratory Glossitis
NCT05190562 ·Status: COMPLETED ·Phase: PHASE4
-
Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era
NCT04434014 ·Status: UNKNOWN
-
Topical Hyaluronic Acid and Recurrent Aphthous Stomatitis.
NCT04265001 ·Status: COMPLETED ·Phase: PHASE3
-
BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent
NCT02068846 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation and Treatment of Oral Soft Tissue Diseases
NCT00001601 ·Status: COMPLETED ·Phase: NA
-
Effect of Natural Antibacterial Mouthwash on Taste, Salivary pH and Bacteria in High Caries Risk pt
NCT03623048 ·Status: UNKNOWN ·Phase: NA
-
Zinc Supplementation in Cirrhotic Patients
NCT02475928 ·Status: UNKNOWN ·Phase: NA
-
Malondialdehyde and Nitrous Oxide as Salivary Biomarkers for Different Oral Lesions
NCT04267419 ·Status: COMPLETED
-
Clinical Evaluation of MucoPEG™ for Xerostomia
NCT04986501 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Artificial Intelligence in Diagnosis and Risk Assessment of Oral Potentially Malignant Disorders
NCT07318922 ·Status: NOT_YET_RECRUITING
-
Oral Mucosal Lesions Among Smokers in an Egyptian Population.
NCT03299595 ·Status: COMPLETED